Prostate Cancer
-
Balancing Early-Stage Prostate Cancer DecisionsChoices about screening and treatment for early-stage prostate cancer are complex and largely personal.
by Kendall K. Morgan
-
An Emerging Treatment for Metastatic Prostate CancerA drug that delivers radioactive particles to prostate cancer cells increases overall survival for metastatic castration-resistant prostate cancer.
by Pamela Rafalow Grossman
-
Forward Look
What’s Next? Spring 2021A new way to evaluate patients with prostate cancer.
by Christina Bennett
-
When Cancer’s Spread Is LimitedPeople with cancer that has spread to only a few locations—called oligometastatic cancer—may benefit from aggressive local treatment.
by Kate Yandell
-
Forward Look
Doing More With LessHypofractionation may allow patients to finish radiation treatment sooner.
by Stephen Ornes
-
The Pandemic’s Impact on Cancer Screening and DetectionDelays in cancer screening and diagnosis due to the COVID-19 pandemic put people at risk.
by Kevin McLaughlin
-
Robotic Surgery and CancerUsing robotic assistants for cancer surgery has become commonplace. Whether cancer patients benefit when a surgeon uses a robot remains unclear.
by Sue Rochman
-
Survivor Profile
A Driving ForceMark Good uses every avenue to spread the news about prostate cancer.
by Lindsey Konkel
-
For Prostate Biopsy, It’s Best to Combine Old and New MethodsUsing an older method of prostate biopsy together with MRI-targeted biopsy more accurately diagnoses prostate cancer than either method alone, a study finds.
by Kate Yandell
-
Forward Look
What’s Next? Winter 2019/2020Treating prostate cancer with fewer side effects.
by Bradley Jones
